This indicates that in highly aggressive melanoma, the functional “marker” ALDH does not discriminate cells with enhanced biological aggressiveness, and ALDH+ subpopulation does not play an exclusive role in tumour initiation and/or in low response to therapy. Here, LDHA is linked to neoplasm.